NMR structural elucidation of myelin basic protein epitope 83-99 implicated in multiple sclerosis
Zinovia Spyranti1, Theodore Tselios, George Deraos
1Department of Pharmacy, University of Patras, 265 04 Panepistimioupoli, Rion, Greece.
Amino Acids
|May 27, 2009
Summary
Myelin basic protein peptide 83-99, crucial in multiple sclerosis, adopts an extended conformation with an alpha-helix. Key residues for T-cell recognition are solvent-exposed, aiding in understanding autoimmune responses.
Area of Science:
- Neuroimmunology
- Structural Biology
- Protein Chemistry
Background:
- Myelin basic protein peptide 83-99 (MBP83-99) is a key epitope in multiple sclerosis (MS).
- Peptide analogues are explored to inhibit experimental autoimmune encephalomyelitis, an MS model.
- Understanding the structure of MBP83-99 is vital for developing MS therapies.
Purpose of the Study:
- To determine the solution structural motif of MBP(83-99).
- To investigate the conformation and key residues involved in T-cell receptor recognition.
- To compare the solution structure with existing solid-state models.
Main Methods:
- 2D (1)H-NMR spectroscopy in dimethyl sulfoxide was employed.
- Nuclear Overhauser Effect (NOE) data was analyzed to determine structural constraints.
- Structural modeling was performed based on NMR-derived information.
Main Results:
- An extended conformation for MBP(83-99) in solution was proposed.
- A defined alpha-helix was identified between Val(87)-Phe(90).
- T-cell receptor recognition residues were found to be solvent-exposed and spatially conserved compared to solid-state models.
Conclusions:
- The solution structure of MBP(83-99) reveals an extended conformation with a localized alpha-helix.
- Solvent accessibility of key residues suggests their importance in immune response.
- Structural similarity between solution and solid-state models provides a consistent basis for therapeutic development in MS.
